Contact Support: 512-708-4678

Newsletter

GET THE BUZZ ON CONTINUING MEDICAL EDUCATION COURSES
New Course Alerts and CME News

Risky Business: Understanding and Attenuating Risk Associated with Disease-Modifying Therapy in Relapsing-Remitting Multiple Sclerosis
neuroscienceCME

Online
Dec 09, 2015 - Dec 09, 2016

In this neuroscienceCME Live and On Demand faculty will share the evidence and their insights with health care providers to enable them to collaboratively engage patients in a discussion about their disease and develop shared treatment goals to improve outcomes in patients with MS.


At the end of this CE activity, participants should be able to:

  • When selecting disease-modifying therapy for a specific patient, include the mechanism of action of each agent and its safety profile into the decision-making process.
  • Identify factors that are of primary importance as targets of treatment in collaboration with your patients with MS.
  • Incorporate a point-of-care decision tool that can be used to explain individual risk and to identify factors that may affect a patients’ risk tolerance as part of a patient-centered approach to care.

The following learning objectives pertain only to those requesting CNE credit:

  • Evaluate disease-modifying therapy for patients with MS, including the mechanism of action of each agent and its safety profile.
  • Describe factors that are of primary imporatance as targets of treatment for patients with MS.
  • Review a point-of-care decision tool that can be used to explain individual risk and to identify factors that may affect a patients’ risk tolerance as part of a patient-centered approach to care.


Neurologists, general practitioners, NP, PA, nurses, pharmacists and other health care professionals interested in multiple sclerosis.

Please click here to see the schedule.

There is no fee for this activity.

Please click here to register for this activity.


CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1.5 continuing education contact hours.

CCMC Credit (Certified Case Managers):
This program has been approved for 1.5 hours by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):

ACPECME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs)

Universal Activity Number: 0376-0000-15-028-L01-P (live programs)

0376-0000-15-028-H01-P (recorded programs)

Activity Type: knowledge-based